Scandinavian ChemoTech AB (SE0009242654)

Overview

Scandinavian ChemoTech AB (publ) is a dynamic company based in Lund, Sweden, specializing in innovative cancer care and pain management solutions. Established in 2013, the company has carved a niche for itself by focusing on the development of cutting-edge medical technologies. Its signature product, IQWave, is specifically designed for electrochemotherapy, targeting various types of cancer such as head and neck cancer, squamous cell carcinoma, and more. Scandinavian ChemoTech strives to make a significant impact in the global healthcare landscape, with its products being marketed in regions including the Middle East, Asia, India, and Africa through a strategic network of distribution channels and partnerships with key opinion leaders in human medicine.

Products and Services

• IQWave

  An innovative electroporation device developed by Scandinavian ChemoTech AB, designed for use in electrochemotherapy. This treatment modality is utilized for a diverse range of cancers including head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and the salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. IQWave's technology enhances the efficacy of chemotherapeutic drugs, offering a new lease of life to patients seeking alternative and effective cancer treatments.

• Vetiqure

  Expanding its expertise into veterinary medicine, Scandinavian ChemoTech has introduced Vetiqure, a specialized treatment solution for pets and animals, including dogs, cats, and horses. Vetiqure is primarily aimed at the treatment of superficial tumors, offering a non-invasive alternative to traditional surgery. This technology embodies the company's commitment to providing comprehensive care solutions, extending its innovative approach from human to veterinary oncology.